BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7108327)

  • 1. [Study on the assessment of antiarrhythmic drug efficacy by Holter electrocardiography (author's transl)].
    Suzuki Y; Ishizaka K; Kobayashi A; Kamikawa T; Hayashi H; Masumura Y; Yamazaki N
    Nihon Naika Gakkai Zasshi; 1982 Apr; 71(4):421-30. PubMed ID: 7108327
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Holter method and treatment of rhythm disorders].
    Lekieffre J; Dupuis B; Libersa C; Anaye B; Théry C; Carré A
    Arch Mal Coeur Vaiss; 1980 Aug; 73(8):895-902. PubMed ID: 6774679
    [No Abstract]   [Full Text] [Related]  

  • 4. [Control of the efficacy of anti-arrhythmic treatments].
    Coumel P
    Schweiz Med Wochenschr; 1981 Nov; 111(45):1688-91. PubMed ID: 7313633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the noninvasive approach.
    Andresen D; Behrens S; Stern R; Brüggemann T; Schröder R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S28-31. PubMed ID: 1279306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute non-invasive test in the selection of anti-arrhythmic drugs. Preliminary study].
    de Berrazueta JR; Poveda J; Sánchez A; Ortiz de Murúa JA; Villarroel MT
    Med Clin (Barc); 1985 Jan; 84(2):54-7. PubMed ID: 3974348
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dynamic electrocardiography--the Holter system. Principal indications and importance of the method].
    de Brito FS
    Arq Bras Cardiol; 1979 Sep; 33(3):197-205. PubMed ID: 543810
    [No Abstract]   [Full Text] [Related]  

  • 8. [The efficacy of anti-arrhythmia therapy with bonnecor in middle-aged and elderly patients].
    Zaslavskaia RM; Mirskiĭ BA; Diagilev II
    Klin Med (Mosk); 1996; 74(2):30-2. PubMed ID: 8772098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor].
    Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C
    Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459
    [No Abstract]   [Full Text] [Related]  

  • 10. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Rizzon P; De Toma L; Mangini SG; Scrutinio D; Lagioia R; De Nicolò M
    Cardiologia; 1983 Sep; 28(9):791-801. PubMed ID: 6398703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and treatment of arrhythmia in ambulatory practice].
    Pomerantsev VP
    Sov Med; 1990; (8):36-40. PubMed ID: 2274818
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation and treatment of ventricular arrhythmias: an update.
    McCollam PL; Parker RB
    Clin Pharm; 1991 Mar; 10(3):195-205. PubMed ID: 2040126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Type and frequency of cardiac arrhythmias dependent on age, therapeutic aspects (author's transl)].
    Wiese KH; Walter J; Schramm A; Gärtner FR; Bracharz M
    Z Kardiol; 1981 Jul; 70(7):516-23. PubMed ID: 6168125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of the Holter monitoring of ischemic heart disease patients].
    Nikolov G; Iungnik A
    Vutr Boles; 1986; 25(1):48-54. PubMed ID: 3716362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of Holter's dynamic ECG a as predictor of the effectiveness of anti-arrhythmia therapy].
    Sanna GP
    G Ital Cardiol; 1986 Aug; 16(8):663-6. PubMed ID: 3792732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy with and assessment of class III antiarrhythmic agents in different patient populations.
    Podrid PJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S44-58. PubMed ID: 1279309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quinidine arabogalactane-sulfate efficiency duration estimate using Holter monitor recording (author's transl)].
    Normand JP; Maspoli JJ; Jarreau C; Schwob J; Collignon I
    Therapie; 1981; 36(5):547-54. PubMed ID: 7323993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrophysiologic effects of intravenous cibenzoline succinate, a new class I antiarrhythmic agent].
    Atarashi H; Iida K; Kou M; Hirayama Y; Gotoh M; Ino T; Katoh T; Hayakawa H
    Kokyu To Junkan; 1988 Oct; 36(10):1119-24. PubMed ID: 3247527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.